Institutional
Patient Square Capital LP
CIK 0001819257
$563.6M
Reported AUM
29
Positions
Q1 2026
Period
2026-05-15
Filed
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ROIV | ROIVANT SCIENCES LTD | $33.24 | 1.13% | 196.20% | 236.68% | $226.2M | 40.13% | — | HELD |
| 2 | ARGX | ARGENX SE | $864.07 | -2.10% | 30.98% | 166.62% | $26.8M | 4.76% | — | HELD |
| 3 | INSM | INSMED INC | $101.53 | -1.54% | -3.85% | 272.72% | $25.8M | 4.57% | — | HELD |
| 4 | ONC | BEONE MEDICINES LTD | $321.62 | -1.71% | 9.22% | 5.93% | $23.9M | 4.24% | — | HELD |
| 5 | COGT | COGENT BIOSCIENCES INC | $39.89 | 0.81% | 247.33% | 378.21% | $22.9M | 4.07% | — | HELD |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | $108.04 | 0.44% | 106.79% | 561.97% | $21.2M | 3.77% | — | HELD |
| 7 | BLTE | BELITE BIO INC | $154.70 | 1.48% | 135.39% | 923.15% | $18.6M | 3.30% | — | HELD |
| 8 | LEGN | LEGEND BIOTECH CORP | $18.61 | -1.27% | -52.04% | -51.40% | $17.9M | 3.18% | — | HELD |
| 9 | NKTR | NEKTAR THERAPEUTICS | $71.43 | 1.06% | 207.32% | -69.61% | $15.1M | 2.68% | — | HELD |
| 10 | DBVT | DBV TECHNOLOGIES S A | $13.51 | -1.60% | 50.00% | 14.02% | $14.5M | 2.57% | — | HELD |
| 11 | PHVS | PHARVARIS N V | $32.96 | 1.04% | 66.05% | 64.49% | $13.9M | 2.47% | — | HELD |
| 12 | ABVX | ABIVAX SA | $121.03 | 1.84% | 65.18% | 1070.84% | $13.5M | 2.40% | — | HELD |
| 13 | XENE | XENON PHARMACEUTICALS INC | $62.73 | -0.59% | 106.89% | 257.51% | $13.2M | 2.34% | — | HELD |
| 14 | CELC | CELCUITY INC | $84.16 | 1.08% | 108.62% | 278.45% | $10.8M | 1.92% | — | HELD |
| 15 | EYPT | EYEPOINT INC | $12.08 | 1.34% | 22.76% | 8.96% | $10.2M | 1.82% | — | HELD |
| 16 | MRK | MERCK & CO INC | $127.67 | -2.06% | 70.49% | 100.41% | $9.6M | 1.71% | — | HELD |
| 17 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.76 | -0.36% | 94.26% | 31.13% | $9.4M | 1.67% | — | HELD |
| 18 | ALLO | ALLOGENE THERAPEUTICS INC | $1.88 | 3.82% | 63.89% | -92.58% | $8.4M | 1.49% | — | HELD |
| 19 | KYMR | KYMERA THERAPEUTICS INC | $104.75 | -0.48% | 143.32% | 68.22% | $8.3M | 1.48% | — | HELD |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | $106.75 | 2.56% | 405.54% | 1.65% | $7.9M | 1.40% | — | HELD |
| 21 | ELVN | ENLIVEN THERAPEUTICS INC | $53.06 | 0.17% | 182.81% | 176.46% | $7.8M | 1.39% | — | HELD |
| 22 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.90 | 1.05% | -22.01% | -55.16% | $6.8M | 1.20% | — | HELD |
| 23 | DFTX | DEFINIUM THERAPEUTICS INC | $42.97 | 1.93% | 396.86% | -3.00% | $6.3M | 1.11% | — | HELD |
| 24 | HROW | HARROW INC | $39.47 | 2.04% | 26.38% | 272.36% | $5.8M | 1.03% | — | HELD |
| 25 | TARA | PROTARA THERAPEUTICS INC | $3.83 | 0.55% | 24.51% | -54.59% | $5.4M | 0.95% | — | HELD |
| 26 | CTMX | CYTOMX THERAPEUTICS INC. | $3.21 | 1.26% | 37.02% | -37.11% | $5.1M | 0.91% | — | HELD |
| 27 | RCUS | ARCUS BIOSCIENCES INC | $27.25 | 3.02% | 191.81% | -8.36% | $4.2M | 0.75% | — | HELD |
| 28 | ASMB | ASSEMBLY BIOSCIENCES INC | $25.05 | -0.26% | 36.11% | -45.08% | $3.8M | 0.67% | — | HELD |
| 29 | SYRE | SPYRE THERAPEUTICS INC | $99.02 | 1.18% | 501.91% | -46.00% | $50K | 0.01% | — | HELD |
Source: SEC EDGAR · accession 0001819257-26-000003. 13F discloses long positions only — shorts, foreign equities, and options are excluded.